• <tbody id="fycq9"></tbody>

  • <em id="fycq9"></em>

    1 / 3

    About Ribo

    Established in 2007, Suzhou Ribo Life Science Co. Ltd. is devoted to the advanced oligonucleotide therapeutics in China including siRNA, antisense and aptamer drugs based on proprietary intellectual properties. The core members of the R&D team include top experts in the fields of siRNA biotechnology, nucleic acid chemistry, drug delivery and development, consisting of both overseas returnees and domestic scientists. Ribo is committed to promoting siRNA and other RNA drugs, as well as technology innovation, in order to deliver more precise and efficient therapies to the patients worldwide.

    Technological Innovations

    Ribo continues to promote innovation of drugs development and the manufacturing process and has established an integrated drug R&D system covering drug design, target validation, drug delivery, quality study, pharmacological, toxicological, and pharmacokinetic evaluation, synthesis of monomers and oligonucleotides, and clinical study.

    siRNA delivery technology platform

    Oligonucleotide modification for enhanced stability platform

    Oligonucleotide therapeutic bioanalysis platform

    CMC Development of Oligonucleotide platform

    Oligonucleotide monomer platform

    Oligonucleotide sequence design and high-throughput screening platform


    Driven by our independent innovation and international partnership, Ribo has built up a robust pipeline of investigational oligonucleotide therapeutics, focusing on the cardio-metabolic diseases, liver diseases, ocular diseases, and rare diseases/other indications.










    Type 2 Diabetes


    Hemophilia A

    原平市| 那曲县| 保亭| 临安市| 琼结县| 大城县| 阜宁县| 九龙坡区| 丘北县| 常熟市| 孝昌县| 喜德县| 银川市| 玉树县| 永德县| 登封市| 温州市| 江门市| 大城县| 辽源市| 临潭县| 靖宇县| 丰台区| 岳西县| 青田县| 平顶山市| 永昌县| 江山市| 汉源县| 荣成市| 舞钢市| 岳普湖县| 胶州市| 瓮安县| 公主岭市| 滁州市| 石家庄市| 元江| 泸西县| 兰考县| 甘德县| http://www.123.com http://www.123.com http://www.124.com